Clinical trial

Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function

NCT00845182

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-06-01

PhasePHASE4

Study timeline

Study start (unknown)2007-06-01Date precision: month

Registry last updated2018-01-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Healthyunresolved

Impaired Glucose Toleranceunresolved

Interventions

PioglitazoneDRUG · verified · RxNorm: pioglitazone

ExenatideDRUG · verified · RxNorm: exenatide

Pioglitazone and ExenatideDRUG

Sponsors & collaborators

The University of Texas Health Science Center at San Antoniolead sponsor

Mapped research locations

San AntonioTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00845182 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.